T cell-based immunotherapy in solid tumors: mechanistic barriers and emerging opportunities
{{output}}
T cell-based immunotherapies have transformed the treatment of hematological malignancies, but their efficacy in solid tumors remains inconsistent. Unlike blood cancers, solid tumors present multiple barriers that impede T cell infiltration, metabolic fitness,... ...
